Idexx Laboratories (IDXX) Non-Current Deferred Revenue (2009 - 2026)
Idexx Laboratories' Non-Current Deferred Revenue came in at $32.71 million for Q3 2026, up 5.3% from $31.05 million a year earlier and up 0.4% from the prior quarter.
Idexx Laboratories (IDXX) Non-Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Idexx Laboratories' Non-Current Deferred Revenue was $32.18 million, up 19.4% from FY2024.
- Non-Current Deferred Revenue carries a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- Going back by year, Non-Current Deferred Revenue was $26.94 million in FY2024 (-5.6%), $28.53 million in FY2023 (-7.5%), $30.86 million in FY2022 (-25.0%) and $41.17 million in FY2021 (-10.8%).
- The Q3 2026 figure represents the highest quarterly Non-Current Deferred Revenue since Q3 2022.
- Year-over-year, Non-Current Deferred Revenue has increased for six consecutive quarters, with growth averaging 9.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deferred Revenue over five years came in Q1 2026 (growth of 20.5%), and the weakest in Q4 2022 (a decline of 25.0%).
- Business Quant data shows IDXX's Non-Current Deferred Revenue at $32.59 million (Q2 2026), $32.31 million (Q1 2026) and $32.18 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Idexx Laboratories | 53.33 Bn | 52.56 Bn | 764.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 32.71 Mn |
| Jun 30, 2026 | 32.59 Mn |
| Mar 31, 2026 | 32.31 Mn |
| Dec 31, 2025 | 32.18 Mn |
| Sep 30, 2025 | 31.05 Mn |
| Jun 30, 2025 | 31.76 Mn |
| Mar 31, 2025 | 26.82 Mn |
| Dec 31, 2024 | 26.94 Mn |
| Sep 30, 2024 | 26.77 Mn |
| Jun 30, 2024 | 26.79 Mn |
| Mar 31, 2024 | 28.04 Mn |
| Dec 31, 2023 | 28.53 Mn |
| Sep 30, 2023 | 27.72 Mn |
| Jun 30, 2023 | 29.05 Mn |
| Mar 31, 2023 | 30.44 Mn |
| Dec 31, 2022 | 30.86 Mn |
| Sep 30, 2022 | 34.74 Mn |
| Jun 30, 2022 | 36.97 Mn |
| Mar 31, 2022 | 39.23 Mn |
| Dec 31, 2021 | 41.17 Mn |
Idexx Laboratories Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();